Key result
Video-assisted Port-Access surgery for atrial myxoma resection in 9 patients resulted in no hospital deaths, no conversions to sternotomy, and no recurrent tumors.
Why the study?
Is video-assisted Port-Access surgery safe and effective for atrial myxoma resection?
Case Report (n=9)
Is video-assisted Port-Access surgery safe and effective for atrial myxoma resection?
Video-assisted Port-Access surgery is a feasible and safe alternative to sternotomy for the resection of atrial myxomas.
The curative treatment of choice for myxomas is surgical removal. Most of the patients are young and active and are focused on postoperative comfort, cosmesis and a fast track to complete rehabilitation, all of which is related to the degree of invasiveness of the intervention. We report our first experience with video-assisted Port-Access surgery for atrial myxoma. From February 1997 until April 2000, nine patients (3M/6F)) had an atrial myxoma resection with the Heartport Endo-CPB and Endo-aortic clamp system. Mean age was 54 +/- 21.9 years. Most of the patients were symptomatic and had good LV function. Two patients had a combined procedure: one mitral valve replacement and one vascular shunt for dialysis. Mean aortic cross clamp time was 69 +/- 32.8 min and mean perfusion time was 103 +/- 42.7 min. There were no conversions to sternotomy. Three patients had minor complications. Mean ICU and hospital stay were 1 +/- 1.4 and 6 +/- 3.9 days respectively. No thromboembolic or peripheral ischaemic complications were observed. There were no hospital deaths. No recurrent tumors have been identified. The Port-Access approach for myxoma resection constitutes a invaluable alternative to sternotomy with the same gold standards of results and quality.
No takes yet. Share an insight, caveat, or question.
Schroeyers et al. (2002) conducted a case report in Atrial myxoma (n=9). Video-assisted Port-Access surgery was evaluated. Video-assisted Port-Access surgery for atrial myxoma resection in 9 patients resulted in no hospital deaths, no conversions to sternotomy, and no recurrent tumors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: